Hindustan Times (Lucknow)
MAHA COMPANY TO PRODUCE 228 MN COVAXIN DOSES ANNUALLY
NEW DELHI : The Centre on Wednesday said that the Maharashtra-owned Haffkine Biopharmaceutical Corp will produce 228 million Covaxin doses per annum as part of a technology transfer arrangement with vaccine maker Bharat Biotech , a move that will increase the number of Covid-19 vaccines produced locally.
The announcement came days after the Centre last week rejected criticism from several states that it was not doing enough to improve vaccine production in the country and said, Haffkine , the national Dairy development Board promoted Indian Immunulogicals and the Centre-owned Bharat Immunologicals and Biologicals will together aim to produce up to 40 million doses of Covid-19 vaccines by December. It said this was apart from Bharat Biotech’s own efforts to enhance Covaxin production to 100 million doses per month by October.